Bhanzu Bets Big on the U.S. with Launch of First Physical Math Center in Texas
HYDERABAD, India, Nov. 28, 2025 /PRNewswire/ -- Bhanzu, the fastest-growing global math…
Sequana Medical Announces First U.S. Commercial alfapump Implantation at Mount Sinai Hospital in New York
Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough…
Solidion Technology Awarded Grant From The U.S. Department of Energy
Grant Proceeds Will Accelerate Research and Commercialization of Electrochemical Manufacturing of High-Performance…
NYSE Content Advisory: Pre-Market Update + U.S. Economy Adds 119,000 Jobs in September
NEW YORK, Nov. 21, 2025 /PRNewswire/ -- The New York Stock Exchange…
United States Hosts 1.2 Million International Students at Colleges and Universities, Totaling 6% of U.S. Higher Education
WASHINGTON, Nov. 17, 2025 /PRNewswire/ -- Today, the Open Doors® 2025 Report on…
Following the Divestiture of Loss-Making Operations, Token Cat Limited Authorizes Its U.S. Subsidiary to Evaluate a Potential $ 500 Million Fundraising Plan for Nuclear Fission Research and M&A to Address the Growing Clean Energy Demand of AI Computing
BEIJING, Nov. 14, 2025 /PRNewswire/ -- Token Cat Limited (Nasdaq: TC) today announced…
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATIONREGULATED INFORMATION Correction and ReplacementNyxoah Secures Financing Commitments of up to…
XTEND WINS A MULTI-MILLION-DOLLAR U.S. DEPARTMENT OF WAR (DOW) CONTRACT TO DEVELOP AND DELIVER AI-ENABLED AFFORDABLE CLOSE QUARTER MODULAR ONE-WAY ATTACK DRONE (OWA) KIT
TAMPA, Fla., Nov. 11, 2025 /PRNewswire/ -- Veterans Day – The Office…
From Pre-Orders to PresenceBreakthrough Emotion-Tracking Pendant, NUNA, Officially Launches in U.S. Ahead of Holiday Season
HONG KONG, Nov. 10, 2025 (GLOBE NEWSWIRE) -- NUNA pendant arrives at…
Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase…
